The Asia Pacific vascular access device market will grow moderately through 2027, driven by an expanding patient population and increasing adoption of premium-priced devices.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for vascular access devices in the Asia Pacific countries across a 10-year period.
Despite increasing failure rates and complications requiring reinsertion, short PIVC insertions continue to be one of the most common invasive procedures in the region.
What are the current clinical recommendations to reduce PIVC failure?
What are some of the measures taken by companies to improve PIVC insertion outcomes?
How will initiatives to educate nurses on PIVC insertion impact the unit sales of short PIVC?
Increasing incidence of CLABSI with CVC is resulting in a shift toward PICCs.
How is the rising adoption of PICCs impacting the sales of CVC units? How does this vary across the Asia Pacific countries?
What are the marketing strategies adopted by companies to promote PICC sales?
What are some of the clinical practices initiated to reduce CLABSI with CVCs? How will this impact the CVC market?
How will the markets for tunneled CVCs and antimicrobial devices perform through 2027?
Home care therapy continues to grow in most Asia Pacific countries.
What are some of the vascular access device markets likely to be impacted by the increasing adoption of home care therapy?
- Vascular Access Devices - Market Insights - Asia Pacific
Author(s): Sangeetha Iyer, Pharm.D
Sangeetha Iyer is an analyst within the Cardiovascular Medtech Insights team at Decision Resource Group, specializing in structural heart closure and vascular access device markerts across the Asia Pacific region, as well as medical device pricing and regulations in China and Japan. Sangeetha has represnted India at the European Society of Cardiology confrerence in Greece(2016) and Sweden(2017), where her research poster was awarded the top prize. Sangeetha holds a Doctor of Pharmacy degree from the Manipal Academy of Higher Education. Follow Sangeetha on twitter: @Slyer_DRG